WallStreetZenWallStreetZen

NASDAQ: EYEN
Eyenovia Inc Stock

$2.59+0.12 (+4.86%)
Updated May 26, 2023
EYEN Price
$2.59
Fair Value Price
$3.27
Market Cap
$98.43M
52 Week Low
$1.50
52 Week High
$5.85
P/E
-3.5x
P/B
6.22x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$26.41M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.85
Operating Cash Flow
-$24M
Beta
0.65
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

EYEN Overview

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EYEN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EYEN ($2.59) is undervalued by 20.78% relative to our estimate of its Fair Value price of $3.27 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
EYEN ($2.59) is significantly undervalued by 20.78% relative to our estimate of its Fair Value price of $3.27 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
EYEN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EYEN due diligence checks available for Premium users.

Be the first to know about important EYEN news, forecast changes, insider trades & much more!

EYEN News

Valuation

EYEN fair value

Fair Value of EYEN stock based on Discounted Cash Flow (DCF)
Price
$2.59
Fair Value
$3.27
Undervalued by
20.78%
EYEN ($2.59) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EYEN ($2.59) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EYEN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EYEN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.5x
Industry
11.86x
Market
54.23x

EYEN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.22x
Industry
5.18x
EYEN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EYEN's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.7M
Profit Margin
0%
EYEN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$29.3M
Liabilities
$13.5M
Debt to equity
0.85
EYEN's short-term assets ($24.92M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EYEN's short-term assets ($24.92M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EYEN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EYEN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.0M
Investing
-$838.1k
Financing
$3.4M
EYEN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EYEN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
EYEN$98.43M+4.86%-3.50x6.22x
ETON$98.37M+1.77%-16.07x8.75x
DBTX$97.81M-8.86%-1.58x1.40x
ADVM$99.77M+3.33%-0.68x0.63x
ATHA$99.81M-2.59%-0.97x0.47x

Eyenovia Stock FAQ

What is Eyenovia's quote symbol?

(NASDAQ: EYEN) Eyenovia trades on the NASDAQ under the ticker symbol EYEN. Eyenovia stock quotes can also be displayed as NASDAQ: EYEN.

If you're new to stock investing, here's how to buy Eyenovia stock.

What is the 52 week high and low for Eyenovia (NASDAQ: EYEN)?

(NASDAQ: EYEN) Eyenovia's 52-week high was $5.85, and its 52-week low was $1.50. It is currently -55.73% from its 52-week high and 72.67% from its 52-week low.

How much is Eyenovia stock worth today?

(NASDAQ: EYEN) Eyenovia currently has 38,002,965 outstanding shares. With Eyenovia stock trading at $2.59 per share, the total value of Eyenovia stock (market capitalization) is $98.43M.

Eyenovia stock was originally listed at a price of $9.92 in Jan 25, 2018. If you had invested in Eyenovia stock at $9.92, your return over the last 5 years would have been -73.89%, for an annualized return of -23.55% (not including any dividends or dividend reinvestments).

How much is Eyenovia's stock price per share?

(NASDAQ: EYEN) Eyenovia stock price per share is $2.59 today (as of May 26, 2023).

What is Eyenovia's Market Cap?

(NASDAQ: EYEN) Eyenovia's market cap is $98.43M, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eyenovia's market cap is calculated by multiplying EYEN's current stock price of $2.59 by EYEN's total outstanding shares of 38,002,965.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.